Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × obinutuzumab × 30 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 9 Lymphoma, Non-Hodgkin 7 Lymphoma 5 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Recurrence 3 Neoplasms 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, B-Cell 2 Burkitt Lymphoma 2 Lymphatic Diseases 1 Leukemia, Hairy Cell 1 Leukemia, B-Cell 1 Leukemia 1 Heart Failure 1 Cytokine Release Syndrome 1

Interventions

pembrolizumab 7 Cisplatin 6 Paclitaxel 5 toripalimab 2 Radiotherapy 2 Irinotecan 2 Fluorouracil 2 Drug Therapy 2 Carboplatin 2 tislelizumab 1 regorafenib 1 nimotuzumab 1 lenvatinib 1 aflibercept 1 Oxaliplatin 1 Nivolumab 1 NEO212 1 Levoleucovorin 1 Leucovorin 1 Ipilimumab 1 IFL protocol 1 Histamine H2 Antagonists 1 Histamine Antagonists 1 Fulvestrant 1 Docetaxel 1 Dexamethasone 1 Chemoradiotherapy 1 Bevacizumab 1 Acetaminophen 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡